COMMUNIQUÉS West-GlobeNewswire

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
24/03/2025
Châtillon, France, March 24, 2025 DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for Biologics License Application (BLA) for Viaskin® Peanut Patch in 4 – 7-year-olds, Accelerating the [...]
DBV Technologies conclut un accord avec la FDA sur les données d'innocuité requises pour la demande de BLA du patch Viaskin® Peanut chez les enfants de 4-7 ans, accélérant ainsi au premier semestre 2026 le dépôt de la demande…
24/03/2025
Châtillon, France, le 24 mars (7h30 CEST) 2024 DBV Technologies conclut un accord avec la FDA sur les données d'innocuité requises pour la demande de licence de produit biologique (BLA) du patch Viaskin® Peanut chez les [...]
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round
24/03/2025
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing investors Proceeds to [...]
Santhera to share latest on commercial rollout of AGAMREE® and future strategic priorities at Capital Markets Day
24/03/2025
Pratteln, Switzerland, March 24, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that at its Capital Markets Day (CMD) in Zurich today, the Company will discuss the commercial progress with the global roll-out of [...]
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
24/03/2025
Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly intensifying in [...]
Valneva répond à l'appel du gouvernement français pour la fourniture du vaccin IXCHIQ® contre l'épidémie de chikungunya à La Réunion
24/03/2025
Saint Herblain (France), le 24 mars 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui qu’elle répondait avec son vaccin IXCHIQ ® à l’épidémie de [...]
Opthea Announces COAST Phase 3 Trial Topline Results
24/03/2025
COAST Phase 3 trial failed to meet primary endpoint of mean change in BCVA from baseline to week 52 Opthea considering impact of negative trial results under its Development Funding Agreement and on the Company as a [...]
Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma
24/03/2025
SHANGHAI, March 23, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
23andMe Initiates Voluntary Chapter 11 Process to Maximize Stakeholder Value Through Court-Supervised Sale Process
24/03/2025
Intends to use Proceedings to Conduct a Value-Maximizing Sale Process and Resolve Liabilities Company Expects to Continue Business Operations in the Ordinary Course During Proceedings; Secures Commitment for [...]
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025
23/03/2025
SOUTH SAN FRANCISCO, Calif., March 23, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today [...]
Ever Joint Benefits: How This Supplement Supports Flexibility and Weight Loss
22/03/2025
TALLMADGE, Ohio, March 22, 2025 (GLOBE NEWSWIRE) -- Weight management remains a paramount concern for many individuals in the ever-evolving health and wellness world. In pursuit of practical solutions, countless [...]
Best Steroids For Bodybuilding (Muscle Growth & Bulking) From CrazyBulk in 2025
22/03/2025
NEW YORK, March 22, 2025 (GLOBE NEWSWIRE) -- “ CrazyBulk Stacks. Want the best results? Then you gotta stack it. Each stack features our very best bodybuilding supplements which work synergistically together to give you [...]
Financière de Tubize - Annual report 2024
22/03/2025
Annual Report 2024 Regulated information 22 March 2025 The board of directors of Financière de Tubize has established the 2024 annual report. This report is available on the website www.financiere-tubize.be Profit for [...]
Financière de Tubize - Rapport annuel
22/03/2025
Rapport annuel 2024 Informations réglementées - 22 mars 2025 Le conseil d’administration de la Financière de Tubize a établi le rapport annuel 2024. Ce rapport est disponible sur le site internet www.financiere-tubize. [...]
Prime Biome Reviews 2025 (Investigative Report) Ingredients, Benefits, Complaints, And Honest Consumer Report!
22/03/2025
ST. PETERSBURG, Fla., March 22, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a probiotic for skin and digestion that helps rejuvenate the skin by replacing old cells with new ones. The supplement is said to maintain the skin [...]
Arialief Reviews (Is It Safe And Legit To Use?) What Do Arialief Consumer Reports Say About Its Efficacy?
22/03/2025
AURORA, Colo., March 22, 2025 (GLOBE NEWSWIRE) -- Arialief is a unique nerve pain and discomfort relief supplement with natural herbs and powerful ingredients. The unique composition of the formula makes it stand out [...]
ProDentim Reviews (2025) Is This Probiotic Formula Really A Game-Changer For Teeth And Gum Health?
22/03/2025
TALLMADGE, Ohio, March 22, 2025 (GLOBE NEWSWIRE) -- qProDentim is designed to improve oral health naturally. It contains carefully chosen ingredients to balance the oral microbiome. It fights against harmful bacteria to [...]
Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.
22/03/2025
Company Announcement AbbVie Inc. files complaint against Genmab in the U.S. District Court for the Western District of Washington (Seattle) Genmab categorically refutes allegations and will vigorously defend the company [...]
Atea Pharmaceuticals Issues Statement Regarding Director Nominations
21/03/2025
No Shareholder Action is Required at this Time BOSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company) a clinical-stage biopharmaceutical company engaged in the discovery [...]

Pages